The Latest Breaking News from diabetes

As a pediatrician, I thought my medical background and pediatric training meant I would be well prepared to breastfeed my newborn. I knew all about the research on how an infant’s diet can affect both their short- and long-term health. Compared to formula, breastfeeding is linked to a lower risk…

Researchers estimate around one in seven black men and one in 63 South Asian men are affected, compared with fewer than one in 100,000 white men.

Eli Lilly and Company (NYSE: LLY) shares are trading lower after the company ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began. The termination is a setback for Lilly’s obesity pipeline among growing investor expectations.

Diabetes mellitus – known to many as type 1 and type 2 diabetes – gets all the attention with its rising global prevalence and connection to lifestyle and autoimmunity. Meanwhile, its lesser-known relative – diabetes insipidus – more quietly affects hundreds of thousands of people worldwide, but is an altogether…

On Wednesday, Eli Lilly Co. (NYSE: LLY) ended a mid-stage study of its experimental drug bimagrumab in obesity patients with type 2 diabetes, just weeks after it began.

A major new analysis is drawing fresh attention to the possible links between gestational diabetes and long-term brain health in both mothers and their children. The review, which combined data from 48 studies conducted over nearly 50 years, suggests that diabetes during pregnancy may have effects that extend well beyond…

Study finds body’s ‘built-in backup plan’ for diabetes-controlling hormone production

"Whose baby is this? He came out of me?"

On Friday, Skye Bioscience, Inc. (NASDAQ:SKYE) announced the presentation of results from the Phase 1b study of nimacimab in subjects with metabolic-associated steatotic liver disease (MASLD) at the European Association for the Study of Diabetes (EASD) Annual Meeting.